|
1
|
A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region.
|
Hum Mol Genet
|
2011
|
1.28
|
|
2
|
Identification of the smallest structure capable of evoking opsonophagocytic antibodies against Streptococcus pneumoniae type 14.
|
Infect Immun
|
2008
|
1.02
|
|
3
|
Th1-directing adjuvants increase the immunogenicity of oligosaccharide-protein conjugate vaccines related to Streptococcus pneumoniae type 3.
|
Infect Immun
|
2003
|
1.01
|
|
4
|
Assessment of antibody response elicited by a 7-valent pneumococcal conjugate vaccine in pediatric human immunodeficiency virus infection.
|
Clin Diagn Lab Immunol
|
2005
|
0.96
|
|
5
|
Gold nanoparticles as carriers for a synthetic Streptococcus pneumoniae type 14 conjugate vaccine.
|
Nanomedicine (Lond)
|
2012
|
0.93
|
|
6
|
Short-chain oligosaccharide protein conjugates as experimental pneumococcal vaccines.
|
Indian J Med Res
|
2004
|
0.90
|
|
7
|
Codelivery of adjuvants at the primary immunization site is essential for evoking a robust immune response to neoglycoconjugates.
|
Vaccine
|
2010
|
0.82
|
|
8
|
The immune response to group B streptococcus type III capsular polysaccharide is directed to the -Glc-GlcNAc-Gal- backbone epitope.
|
Glycoconj J
|
2011
|
0.79
|
|
9
|
High sensitive detection of carbohydrate binding proteins in an ELISA-solid phase assay based on multivalent glyconanoparticles.
|
PLoS One
|
2013
|
0.78
|
|
10
|
Antibody- and cell-mediated immune responses to a synthetic oligosaccharide conjugate vaccine after booster immunization.
|
Vaccine
|
2011
|
0.76
|